semaglutide and sour stomach Semaglutide (commonly known as Ozempic® or Wegovy®) is administered through a simple subcutaneous injection, allowing the Stomach turning after starting GLP-1

It also improves training output, which reinforces your ability to stay active while in a calorie deficit

Victozas A1c reductions in the LEAD program ranged from about 1.0-1.5%, which are clinically meaningful but more modest

Dermatol 19, 12841289

Where these numbers came from: The orforglipron data is from Lillys August 2025 press release on the ATTAIN-1 trial

Medication and Provider Background: The client was prescribed Wegovy, a GLP-1 medication, by her primary care physician (PCP) to address PCOS (Polycystic Ovary Syndrome) and prediabetes

Glucagon agonism can affect hepatic glucose output and lipid metabolism, and its long-term effects on liver function and cardiovascular risk require careful evaluation